Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Future Oncology (London, England)|November 12, 2014
Eribulin: a new-generation antimicrotubule agent in lung cancer therapyEddie Thara, Barbara J GitlitzThe Urologic Clinics of North America|September 5, 2003
Cytokine-based therapy for metastatic renal cell cancerBarbara J Gitlitz, Robert A FiglinFrontiers in Oncology|June 12, 2013
Epigenetic therapy in lung cancerStephen V Liu, Muller Fabbri, Barbara J Gitlitz, et al.International Journal of Cancer|September 2, 2003
Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patientsSylvia M Kiertscher, Barbara J Gitlitz, Robert A Figlin, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2003
Phase I trial of granulocyte macrophage-colony stimulating factor and interleukin-4 as a combined immunotherapy for patients with cancerBarbara J Gitlitz, Robert A Figlin, Sylvia M Kiertscher, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
A randomized, placebo-controlled, multicenter, biomarker-selected, phase 2 study of apricoxib in combination with erlotinib in patients with advanced non-small-cell lung cancerBarbara J Gitlitz, Eric Bernstein, Edgardo S Santos, et al.Radiology|May 7, 2004
Metastatic renal cell carcinoma: CT-guided immunotherapy as a technically feasible and safe approach to delivery of gene therapy for treatmentRobert D Suh, Jonathan G Goldin, Amanda B Wallace, et al.JTO Clinical and Research Reports|November 8, 2021
Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLCJay M Lee, Anthony W Kim, Tomasz Marjanski, et al.The Journal of Urology|December 18, 2001
Collecting duct renal cell carcinoma: clinical study of a rare tumorDebby Chao, Amnon Zisman, Allan J Pantuck, et al.Cancer|October 30, 2003
A phase II study of gemcitabine and docetaxel therapy in patients with advanced urothelial carcinomaBarbara J Gitlitz, Carole Baker, Yvonne Chapman, et al.Pageof 5